Skip to content

Noise Exposure and Near-Infrared Light

Effects of Noise Exposure and Near Infrared Light (NIL) on Auditory Health and Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03834714
Enrollment
14
Registered
2019-02-08
Start date
2020-02-18
Completion date
2021-12-23
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss, Noise-Induced

Keywords

Noise induced hearing loss, Near infrared energy, Hering test

Brief summary

The primary objective of this work is to determine the effect noise has on the auditory system (both auditory health and performance) and also the degree to which the effect of pre-noise therapy such as Near Infrared (NIR) light can mitigate the effects of noise exposure.

Interventions

NIR Light Therapy will be administered with the Earlight Generation 1.4 device during 2 out of the 4 sessions. It will be administered to each ear individually for 30 minutes per ear.

OTHERNoise Stimulus

Noise stimulus will be administered, open ear, to continuous broadband noise up to 25% of the allowable daily dose of noise per the AFI 48-127 Occupational Noise and Hearing Conservation Program.

DEVICESham Near Infrared Light

Sham NIR Light Therapy will be administered with the Earlight Generation 1.4 device during 2 out of the 4 sessions. It will be administered to each ear individually for 30 minutes per ear.

Sponsors

Office of Naval Research (ONR)
CollaboratorFED
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-45 years old, male or female * Pass hearing exam with a threshold of 25 decibels (dB) hearing or less, for each ear, for all frequencies tested from 500 Hz to 8000 Hz * Normal otoscopic exam, otoacoustic emissions (OAEs), and middle ear function as demonstrated by a normal tympanogram * Completion of a hearing history questionnaire

Exclusion criteria

* Screening hearing test failure * Pregnant females * Adults unable to provide consent * History of significant ear surgery

Design outcomes

Primary

MeasureTime frameDescription
Change in auditory thresholdBaseline, up to 365 daysAuditory function tests will be measured through the change in air conduction threshold measurements from 500 up to 8000 Hz

Secondary

MeasureTime frameDescription
Change in otoacoustic emissions (OAE)Baseline, up to 365 daysAuditory performance will be measured through OAE testing
Change in central auditory performance (CAP)Baseline, up to 365 daysAuditory performance will be measured through central auditory processing assessments

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026